slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 21,541-21,570
Pages 1,349
Rows per page 30
Beat
21,541-21,570 of 40,452
10
Azek | Results Presentation Deck | 16 slidesAzek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · VisualizationLoop · Why Now1 hit
11
The slide provides specific financial ranges for key metrics including Net Sales, EPS, EBITDA, and other operational expenses.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · VisualizationLoop · Why Now1 hit
12
Management estimates.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · VisualizationLoop · Why Now1 hit
08
The slide uses a mix of bar charts and donut charts to visualize revenue composition and growth metrics.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
09
Unconsolidated revenue change vs 2Q21, in millions USD.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
10
The slide uses a 2x2 grid layout to present segment-specific financial performance and qualitative drivers.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
11
The slide uses a combination of bar charts for total revenue and donut charts for segment composition.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
12
The table is split into two main blocks: 2Q22 performance and YTD performance, with sub-totals for Bausch Pharma + Solta, Bausch+Lomb, and Total Bausch Health.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
13
Bausch Health Companies | Results Presentation Deck | 50 slidesBausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
14
Includes footnotes regarding non-GAAP measures, share counts, and exclusions.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
21
Bausch Health Companies | Results Presentation Deck | 50 slidesBausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
22
The slide uses a 2x2 grid layout to categorize strategic priorities by business unit.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
23
The slide uses a circular diagram to represent organizational values/pillars surrounding the company name.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
04
The slide uses a 2x5 grid layout to display 10 team members.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Team1 hit
16
Uses a temporal progression layout (Today -> Mid-term -> Long-term).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
17
Includes product image and key performance metrics.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
18
Slide highlights both historical traction (>3.6bn doses) and future growth vectors (label expansion, boosters, next-gen vaccines).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
19
The slide uses a two-column layout to contrast the 'why' (medical need) with the 'how' (technologies).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
20
The chart uses a horizontal bar representation to indicate the clinical stage of each program.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
21
The diagram illustrates a circular, iterative process (flywheel) connecting patient samples and variability to specific drug classes.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
22
The slide uses a hub-and-spoke diagram to show how various modalities converge on patient care.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
23
The slide uses a Gantt-style visualization to show clinical trial phases for various drug candidates.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
24
The slide uses a matrix structure to compare different drug development programs.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
11
The slide uses a football field chart format to compare valuation ranges across different financial methodologies.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Benchmark Gap1 hit
12
BMO Capital Markets branding present; slide 11 of Project Asterix.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Benchmark Gap1 hit
13
MI 61-101 refers to Multilateral Instrument 61-101, a Canadian regulation regarding protection of minority security holders in special transactions.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Benchmark Gap1 hit
14
BMO Capital Markets | Investment Banking Pitch Book | 22 slidesBMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Benchmark Gap1 hit
15
The slide shows a two-stage buildup: first calculating the Oyu Tolgoi asset value, then adding corporate-level adjustments to arrive at the final NAVPS.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Benchmark Gap1 hit
08
The slide uses a three-column layout to present market size, competitive landscape, and financial targets.Cazoo | Investor Presentation Deck | 16 slides · Cazoo
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
09
The slide presents key performance indicators (KPIs) for Cazoo, showing significant year-over-year growth in both units sold and revenue.Cazoo | Investor Presentation Deck | 16 slides · Cazoo
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit